Canada markets open in 4 hours 43 minutes

Salarius Pharmaceuticals, Inc. (SLRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4780+0.0148 (+3.20%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
5,233
-
Operating Expenses
Research Development
3,691
7,174
15,837
8,549
6,914
-
Selling General and Administrative
5,555
5,721
7,138
6,105
6,106
-
Total Operating Expenses
9,246
12,895
22,975
12,813
12,844
-
Operating Income or Loss
-9,246
-12,895
-22,975
-12,813
-7,611
-
Total Other Income/Expenses Net
-
-
-8,851
44.693
258.551
1,311
Income Before Tax
-8,917
-12,543
-31,608
-12,768
-7,352
-
Income from Continuing Operations
-8,917
-12,543
-31,608
-12,768
-7,352
-
Net Income
-8,917
-12,543
-31,608
-12,768
-7,352
-
Net Income available to common shareholders
-8,917
-12,543
-31,608
-12,768
-7,749
-
Basic EPS
-6.59
-3.84
-14.88
-7.72
-12.50
-
Diluted EPS
-6.59
-3.84
-14.88
-7.72
-12.50
-
Basic Average Shares
2,842
3,265
2,125
1,655
623.144
-
Diluted Average Shares
2,842
3,265
2,125
1,655
623.144
-